122 related articles for article (PubMed ID: 23000699)
1. Modeling of non-covalent complexes of the cell-penetrating peptide CADY and its siRNA cargo.
Crowet JM; Lins L; Deshayes S; Divita G; Morris M; Brasseur R; Thomas A
Biochim Biophys Acta; 2013 Feb; 1828(2):499-509. PubMed ID: 23000699
[TBL] [Abstract][Full Text] [Related]
2. Insight into the cellular uptake mechanism of a secondary amphipathic cell-penetrating peptide for siRNA delivery.
Konate K; Crombez L; Deshayes S; Decaffmeyer M; Thomas A; Brasseur R; Aldrian G; Heitz F; Divita G
Biochemistry; 2010 Apr; 49(16):3393-402. PubMed ID: 20302329
[TBL] [Abstract][Full Text] [Related]
3. Optimisation of vectorisation property: A comparative study for a secondary amphipathic peptide.
Konate K; Lindberg MF; Vaissiere A; Jourdan C; Aldrian G; Margeat E; Deshayes S; Boisguerin P
Int J Pharm; 2016 Jul; 509(1-2):71-84. PubMed ID: 27224007
[TBL] [Abstract][Full Text] [Related]
4. A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells.
Crombez L; Aldrian-Herrada G; Konate K; Nguyen QN; McMaster GK; Brasseur R; Heitz F; Divita G
Mol Ther; 2009 Jan; 17(1):95-103. PubMed ID: 18957965
[TBL] [Abstract][Full Text] [Related]
5. Direct translocation as major cellular uptake for CADY self-assembling peptide-based nanoparticles.
Rydström A; Deshayes S; Konate K; Crombez L; Padari K; Boukhaddaoui H; Aldrian G; Pooga M; Divita G
PLoS One; 2011; 6(10):e25924. PubMed ID: 21998722
[TBL] [Abstract][Full Text] [Related]
6. Everything you always wanted to know about CADY-mediated siRNA delivery* (* but afraid to ask).
Konate K; Rydstrom A; Divita G; Deshayes S
Curr Pharm Des; 2013; 19(16):2869-77. PubMed ID: 23140452
[TBL] [Abstract][Full Text] [Related]
7. A non-covalent peptide-based strategy for siRNA delivery.
Crombez L; Divita G
Methods Mol Biol; 2011; 683():349-60. PubMed ID: 21053142
[TBL] [Abstract][Full Text] [Related]
8. PEP and CADY-mediated delivery of fluorescent peptides and proteins into living cells.
Kurzawa L; Pellerano M; Morris MC
Biochim Biophys Acta; 2010 Dec; 1798(12):2274-85. PubMed ID: 20188697
[TBL] [Abstract][Full Text] [Related]
9. Design and characterization of a new peptide vector for short interfering RNA delivery.
Chen B; Xu W; Pan R; Chen P
J Nanobiotechnology; 2015 Jun; 13():39. PubMed ID: 26054932
[TBL] [Abstract][Full Text] [Related]
10. Effect of arginine-rich peptide length on the structure and binding strength of siRNA-peptide complexes.
Kim M; Kim HR; Chae SY; Larson RG; Lee H; Park JC
J Phys Chem B; 2013 Jun; 117(23):6917-26. PubMed ID: 23697608
[TBL] [Abstract][Full Text] [Related]
11. Self-assembled peptide (CADY-1) improved the clinical application of doxorubicin.
Li Y; Zheng X; Cao Z; Xu W; Zhang J; Gong M
Int J Pharm; 2012 Sep; 434(1-2):209-14. PubMed ID: 22688249
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous membrane interaction of amphipathic peptide monomers, self-aggregates and cargo complexes detected by fluorescence correlation spectroscopy.
Vasconcelos L; Lehto T; Madani F; Radoi V; Hällbrink M; Vukojević V; Langel Ü
Biochim Biophys Acta Biomembr; 2018 Feb; 1860(2):491-504. PubMed ID: 28962904
[TBL] [Abstract][Full Text] [Related]
13. A retro-inverso cell-penetrating peptide for siRNA delivery.
Vaissière A; Aldrian G; Konate K; Lindberg MF; Jourdan C; Telmar A; Seisel Q; Fernandez F; Viguier V; Genevois C; Couillaud F; Boisguerin P; Deshayes S
J Nanobiotechnology; 2017 Apr; 15(1):34. PubMed ID: 28454579
[TBL] [Abstract][Full Text] [Related]
14. Peptide-ligand binding modeling of siRNA with cell-penetrating peptides.
García-Sosa AT; Tulp I; Langel K; Langel Ü
Biomed Res Int; 2014; 2014():257040. PubMed ID: 25147791
[TBL] [Abstract][Full Text] [Related]
15. Hydrophobic and electrostatic interactions between cell penetrating peptides and plasmid DNA are important for stable non-covalent complexation and intracellular delivery.
Upadhya A; Sangave PC
J Pept Sci; 2016 Oct; 22(10):647-659. PubMed ID: 27723187
[TBL] [Abstract][Full Text] [Related]
16. A new amphipathic, amino-acid-pairing (AAP) peptide as siRNA delivery carrier: physicochemical characterization and in vitro uptake.
Jafari M; Xu W; Naahidi S; Chen B; Chen P
J Phys Chem B; 2012 Nov; 116(44):13183-91. PubMed ID: 23077976
[TBL] [Abstract][Full Text] [Related]
17. Structural polymorphism of non-covalent peptide-based delivery systems: highway to cellular uptake.
Deshayes S; Konate K; Aldrian G; Crombez L; Heitz F; Divita G
Biochim Biophys Acta; 2010 Dec; 1798(12):2304-14. PubMed ID: 20541523
[TBL] [Abstract][Full Text] [Related]
18. Insights into membrane translocation of the cell-penetrating peptide pVEC from molecular dynamics calculations.
Alaybeyoglu B; Sariyar Akbulut B; Ozkirimli E
J Biomol Struct Dyn; 2016 Nov; 34(11):2387-98. PubMed ID: 26569019
[TBL] [Abstract][Full Text] [Related]
19. Insight into the role of physicochemical parameters in a novel series of amphipathic peptides for efficient DNA delivery.
Sharma R; Shivpuri S; Anand A; Kulshreshtha A; Ganguli M
Mol Pharm; 2013 Jul; 10(7):2588-600. PubMed ID: 23725377
[TBL] [Abstract][Full Text] [Related]
20. Multiscale modeling of the cellular uptake of C6 peptide-siRNA complexes.
Purijjala PWCM; Rathnayake PVGM; Kumara BT; Gunathunge BCM; Ranasinghe RAAP; Karunaratne DN; Ranatunga RJKU
Comput Biol Chem; 2022 Jun; 98():107679. PubMed ID: 35462199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]